ResMed Inc. stock rises Monday, outperforms market
Shares of ResMed Inc. RMD inched 0.51% higher to $246.18 Monday, on what proved to be an all-around great trading session for ...
ResMed投资者日前景稳定，分析师持谨慎态度
Needham在周三维持对ResMed (NYSE:RMD)的持有评级，该公司是一家以生产睡眠相关产品闻名的医疗设备公司。这一立场是在ResMed定于2024年9月30日在纽约市举行投资者日之前做出的。这是自2021年9月以来公司首次举办此类活动，凸显了过去三年公司发生的重大变化。 ResMed在疫情后供应链已恢复正常，并成功从其未评级的竞争对手Philip Respironics那里获得了相当大 ...
Why ResMed Stock Tumbled by 5% Today
Healthcare technology company ResMed's (NYSE: RMD) stock wasn't quite the picture of health on Wednesday. The shares lost ...
ResMed股票评级因潜在市场中断风险被Wolfe下调
周三，Wolfe Research调整了对ResMed (NYSE:RMD)的立场，将股票评级从同业表现下调至表现不佳。该公司还为ResMed设定了180.00美元的新目标价，这一变化反映了对公司未来盈利和市场风险的修正看法。 此次降级是基于对ResMed在未来几年可能面临的竞争压力的预期。 Wolfe Research提到了对礼来预计推出新的阻塞性睡眠呼吸暂停药物的担忧，这可能会显著影响ResM ...
ResMed: Growing Returns With Continuous Acquisitions Led To A Margin Of Safety
ResMed achieved double-digit revenue growth through acquisitions and operating efficiencies, with improving capital ...
ResMed Stock Is S&P 500’s Worst Performer. GLP-1 Drugs Are a Risk.
Wolfe Research downgraded shares of the maker of sleep-apnea airway machines to Underperform from Peer Perform.
Why ResMed's Rally Is Just Getting Started
ResMed's AirSense 11 platform and myAir app enhance patient engagement and efficiency. Check out why I remain bullish on RMD ...
Why is the ResMed share price taking a thumping on Thursday?
Polark's pessimism stems from concerns that Resmed might be poised to lose market share to its pharmaceutical rival Eli Lilly ...
ResMed Inc. stock rises Friday, outperforms market
Shares of ResMed Inc. RMD inched 0.81% higher to $244.94 Friday, on what proved to be an all-around mixed trading session for ...
ig.com4 天
Stock of the day: ResMed
ResMed faces a 3% drop in share price after concerns over Eli Lilly’s Ozempic, which could impact the demand for CPAP ...
Investing1 天
Resmed Inc DRC (RMD)
ResMed (RMD) reported Q2 EPS of $1.66, $0.06 better than the analyst estimate of $1.60. Revenue for the quarter came in at $1.03 million versus the consensus estimate of $990.85 ...
ResMed Inc. (NYSE:RMD) is a favorite amongst institutional investors who own 74%
To get a sense of who is truly in control of ResMed Inc. ( NYSE:RMD ), it is important to understand the ownership structure of the business. With 74% stake, institutions possess the maximum shares in ...